Frederick R. Singer
#128,974
Most Influential Person Now
Frederick R. Singer's AcademicInfluence.com Rankings
Frederick R. Singerphilosophy Degrees
Philosophy
#6181
World Rank
#9177
Historical Rank
Logic
#3372
World Rank
#4519
Historical Rank
Frederick R. Singerbiology Degrees
Biology
#8369
World Rank
#11434
Historical Rank
Biochemistry
#1207
World Rank
#1326
Historical Rank
Download Badge
Philosophy Biology
Frederick R. Singer's Degrees
- PhD Biochemistry University of California, Berkeley
- Doctorate Medicine University of California, San Francisco
Why Is Frederick R. Singer Influential?
(Suggest an Edit or Addition)Frederick R. Singer's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis. (1983) (504)
- Alpha and beta human transforming growth factors stimulate prostaglandin production and bone resorption in cultured mouse calvaria. (1985) (374)
- Alendronate treatment of the postmenopausal osteoporotic woman: effect of multiple dosages on bone mass and bone remodeling. (1995) (368)
- Bisphosphonate treatment inhibits the growth of prostate cancer cells. (2001) (360)
- Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone. (1992) (360)
- Albers-Schönberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene. (2001) (351)
- FUNCTIONAL HYPOPARATHYROIDISM AND PARATHYROID HORMONE END‐ORGAN RESISTANCE IN HUMAN MAGNESIUM DEFICIENCY (1976) (327)
- Nuclear inclusions in Paget's disease of bone. (1976) (265)
- Nonparathyroid humoral hypercalcemia in patients with neoplastic diseases. (1973) (264)
- Isolation and structural identification of 1,25-dihydroxyvitamin D3 produced by cultured alveolar macrophages in sarcoidosis. (1985) (263)
- Skeletal and Hormonal Effects of Magnesium Deficiency (2009) (260)
- Parathyroid hormone secretion in magnesium deficiency. (1978) (252)
- Osteoporosis in men with prostate carcinoma receiving androgen‐deprivation therapy (2004) (216)
- A high prevalence of hypomagnesemia and hypermagnesemia in hospitalized patients. (1983) (210)
- McCune-Albright syndrome and the extraskeletal manifestations of fibrous dysplasia (2012) (197)
- Magnesium deficiency and excess. (1981) (194)
- Characterization and assay of tartrate-resistant acid phosphatase activity in serum: potential use to assess bone resorption. (1987) (194)
- Skeletal resistance to endogenous parathyroid hormone in pateints with early renal failure. A possible cause for secondary hyperparathyroidism. (1975) (190)
- Magnesium deficiency in a medical ICU population (1985) (184)
- Evidence that serum NTx (collagen-type I N-telopeptides) can act as an immunochemical marker of bone resorption. (1997) (172)
- Enhanced RANK ligand expression and responsivity of bone marrow cells in Paget's disease of bone. (2000) (165)
- Vitamin-D-resistant osteomalacia in hemodialysis patients lacking secondary hyperparathyroidism. (1981) (163)
- Genetic linkage of Paget disease of the bone to chromosome 18q. (1997) (160)
- Using biochemical markers of bone turnover in clinical practice. (2008) (158)
- Response of Paget's disease to porcine and salmon calcitonins: effects of long-term treatment. (1974) (154)
- Low serum concentrations of 1,25-dihydroxyvitamin D in human magnesium deficiency. (1985) (154)
- Evidence for both respiratory syncytial virus and measles virus antigens in the osteoclasts of patients with Paget's disease of bone. (1984) (146)
- A Clinical Approach to Diagnosis and Management of Paget's Disease of Bone (2001) (143)
- Parenteral magnesium tolerance testing in the evaluation of magnesium deficiency. (1985) (141)
- Increments in bone mineral density of the lumbar spine and hip and suppression of bone turnover are maintained after discontinuation of alendronate in postmenopausal women. (1997) (138)
- 1,25-dihydroxycholecalciferol. Effect on skeletal lesions and plasma parathyroid hormone levels in uremic osteodystrophy. (1974) (135)
- Biochemical assessment of bone formation and resorption in acromegaly. (1993) (135)
- An evaluation of antibodies and clinical resistance to salmon calcitonin. (1972) (129)
- The effects of metabolic acidosis on bone formation and bone resorption in the rat. (1986) (128)
- Paget's disease of bone: an endocrine society clinical practice guideline. (2014) (127)
- Urinary excretion of hydroxylysine and its glycosides as an index of collagen degradation. (1977) (124)
- Bone marrow mononuclear cells from patients with Paget's disease contain measles virus nucleocapsid messenger ribonucleic acid that has mutations in a specific region of the sequence. (1995) (121)
- Multimarker circulating DNA assay for assessing blood of prostate cancer patients. (2009) (120)
- Parathyroid hormone-related protein. (1990) (120)
- Mutation of the sequestosome 1 (p62) gene increases osteoclastogenesis but does not induce Paget disease. (2007) (120)
- Evidence for a novel osteosarcoma tumor-suppressor gene in the chromosome 18 region genetically linked with Paget disease of bone. (1998) (114)
- Development of an immunoassay for human serum osteoclastic tartrate-resistant acid phosphatase. (1990) (113)
- Abundant expression of parathyroid hormone-related protein in primary rat aortic smooth muscle cells accompanies serum-induced proliferation. (1991) (113)
- Salmon calcitonin therapy for Paget's disease of bone. The problem of acquired clinical resistance. (1980) (112)
- Rheumatic manifestations of Paget's disease of bone. (1974) (105)
- Cobalamin and osteoblast-specific proteins. (1988) (104)
- Detection of Circulating Tumor Cells in Early-Stage Breast Cancer Metastasis to Axillary Lymph Nodes (2007) (101)
- Bone-resorption markers galactosyl hydroxylysine, pyridinium crosslinks, and hydroxyproline compared. (1992) (92)
- Urinary and nephrogenous adenosine 3',5'-monophosphate in the hypercalcemia of malignancy. (1981) (90)
- Immunohistological demonstration of respiratory syncytial virus antigens in Paget disease of bone. (1981) (88)
- Characteristics of a two-site immunoradiometric assay for human skeletal alkaline phosphatase in serum. (1994) (87)
- Multiple osteocalcin fragments in human urine and serum as detected by a midmolecule osteocalcin radioimmunoassay. (1990) (87)
- Treatment of hypercalcemia of malignancy with intravenous etidronate. A controlled, multicenter study. The Hypercalcemia Study Group. (1991) (85)
- The effects of adjuvant chemotherapy on bone density in postmenopausal women with early breast cancer. (2003) (84)
- Medical Management of Paget's Disease of Bone: Indications for Treatment and Review of Current Therapies (2006) (82)
- Measurement of parathyroid hormone. (1989) (76)
- Immunochemiluminometric and immunoradiometric determinations of intact and total immunoreactive parathyrin: performance in the differential diagnosis of hypercalcemia and hypoparathyroidism. (1991) (73)
- Multiple immunoreactive forms of calcitonin in human plasma. (1974) (73)
- Risedronate, a highly effective oral agent in the treatment of patients with severe Paget's disease. (1998) (72)
- Immunoassay for human calcitonin. II. Clinical studies. (1971) (71)
- Parathyroid gland responsiveness to acute hypocalcemia in dialysis osteomalacia. (1983) (70)
- Abnormalities in osteoclast precursors and marrow accessory cells in Paget's disease. (1993) (68)
- Multinucleated cells formed in vitro from Paget's bone marrow express viral antigens. (1994) (67)
- Failure of disodium etidronate in calcinosis due to dermatomyositis and scleroderma. (1974) (67)
- Sympathetic System Function and Vascular Reactivity in Hypercalcemic Patients (1982) (67)
- ACUTE EFFECTS OF CALCITONIN ON OSTEOCLASTS IN MAN (1976) (65)
- Mithramycin treatment of intractable hypercalcemia due to parathyroid carcinoma. (1970) (65)
- Characterization and management of testicular pathology in McCune-Albright syndrome. (2012) (63)
- Radioimmunoassay for human parathyroid hormone. (1974) (62)
- Vitamin D metabolite-mediated hypercalcemia and hypercalciuria patients with AIDS- and non-AIDS-associated lymphoma. (1989) (62)
- Calcitonin stimulates bone formation when administered prior to initiation of osteogenesis. (1981) (60)
- Acute effects of calcitonin on bone formation in man. (1973) (58)
- Osteoclasts in human osteopetrosis contain viral‐nucleocapsid‐like nuclear inclusions (1988) (57)
- Treatment of thyrotoxic hypercalcemia with propranolol. (1976) (57)
- Abnormal calcium homeostasis in sarcoidosis. (1986) (56)
- Persistent hypercalcemia after successful renal transplantation. (1976) (56)
- Ventilatory effects of dexmedetomidine, atipamezole, and isoflurane in dogs. (1992) (55)
- Stanniocalcin-1: a novel molecular blood and bone marrow marker for human breast cancer. (2003) (54)
- Comparison of serum calcitonin levels after a 1-minute calcium injection and after pentagastrin injection in the diagnosis of medullary thyroid carcinoma. (1977) (50)
- Microfollicular thyroid carcinoma with amyloid rich stroma, resembling the medullary carcinoma of the thyroid (MCT) (1977) (49)
- Cell cultures from bone affected by Paget's disease. (1980) (47)
- Effects of long-term therapy with calcitriol in patients with moderate renal failure. (1980) (47)
- Parathyroid hormone clearance in man. (1978) (47)
- Pharmacokinetics and biologic effects of calcitriol in normal humans. (1985) (46)
- Paget's disease of bone—genetic and environmental factors (2015) (46)
- Peripheral metabolism of bovine parathyroid hormone in the dog. (1975) (46)
- Renal tubular maximum for magnesium in normal, hyperparathyroid, and hypoparathyroid man. (1980) (45)
- Measles virus nucleocapsid transcript expression is not restricted to the osteoclast lineage in patients with Paget's disease of bone. (1999) (44)
- Skeletal response to treatment with 1,25-dihydroxyvitamin D in renal failure. (1980) (41)
- Sentinel Lymph Node Biopsy for Papillary Thyroid Cancer: 12 Years of Experience at a Single Institution (2010) (41)
- Electroencephalographic abnormalities in hypercalcemia (1970) (39)
- Hypercalcemia in reticulum cell sarcoma without hyperparathyroidism of skeletal metastases. (1973) (38)
- PSYCHIATRIC SEQUELAE OF OLD BURNS IN CHILDREN AND THEIR PARENTS. (1964) (37)
- Osteotomy for tibia vara in Paget's disease under cover of calcitonin. (1978) (36)
- Rationale for the use of alendronate in osteoporosis (2005) (35)
- Paget disease: when to treat and when not to treat (2009) (35)
- Bone resorption and humoral hypercalcemia of malignancy: stimulation of bone resorption in vitro by tumor extracts is inhibited by prostaglandin synthesis inhibitors. (1981) (35)
- Body potassium content in obese subjects and potassium depletion during prolonged fasting. (1966) (35)
- Explanation for unusual potency of salmon calcitonin. (1971) (35)
- Some acute effects of administered porcine calcitonin in man. (1969) (35)
- A urine midmolecule osteocalcin assay shows higher discriminatory power than a serum midmolecule osteocalcin assay during short-term alendronate treatment of osteoporotic patients. (2002) (35)
- Human calcitonin treatment of Paget's disease of bone. (1977) (34)
- Radiographic and radionuclide imaging in multiple myeloma: the role of gallium scintigraphy: concise communication. (1981) (34)
- Fibrous dysplasia of bone: the bone lesion unmasked. (1997) (33)
- Introduction to Lipids and Lipoproteins -- Endotext (2000) (33)
- Critical evaluation of viral antigen data in Paget's disease of bone. (1987) (33)
- Production of 1,25‐Dihydroxyvitamin D3 by Pulmonary Alveolar Macrophages from Patients with Sarcoidosis (1986) (33)
- Cinacalcet for the treatment of primary hyperparathyroidism. (2008) (32)
- Prostaglandins: effect on plasma calcium concentration. (1973) (32)
- Hypercalcemia and hypocalcemia. (1977) (32)
- Detection of tumor-specific genetic alterations in bone marrow from early-stage breast cancer patients. (2003) (32)
- Hypercalcemia and abnormal 1,25-dihydroxyvitamin D concentrations in leprosy. (1988) (31)
- Evidence for a viral etiology of Paget's disease of bone. (1983) (31)
- Intestinal calcium absorption in patients with hyperthyroidism. (1980) (31)
- Evaluation of 99mTc diphosphonate kinetics and bone scans in patients with Paget's disease before and after calcitonin treatment. (1977) (31)
- Postpartum resolution of hypocalcemia in a lactating hypoparathyroid patient. (1984) (31)
- The first 24 hours of acute pancreatitis. Changes in biochemical and endocrine homeostasis in patients with pancreatitis compared with those in control subjects undergoing stress for reasons other than pancreatitis. (1978) (30)
- Preliminary trials with 24,25-dihydroxyvitamin D3 in dialysis osteomalacia. (1983) (30)
- A skeletal mineralizing defect in dialysis patients: a syndrome resembling osteomalacia but unrelated to viatamin D. (1980) (30)
- Endocrine complications of AIDS and drug addiction. (1991) (30)
- Bisphosphonates in the treatment of disorders of mineral metabolism. (1995) (29)
- Sequestosome 1 (SQSTM1) Mutations in Paget’s Disease of Bone from the United States (2008) (29)
- Weight of normal parathyroid glands in patients with parathyroid adenomas. (2004) (28)
- 24,25-dihydroxy-cholecalciferol, a vitamin D sterol with qualitatively unique effects in uremic man (1979) (28)
- Immunological stability of calcitonin in plasma. (1972) (27)
- Paget's Disease of Bone: Pathophysiology, Diagnosis, and Management (1995) (27)
- The Genetics of Paget’s Disease of the Bone (2001) (27)
- Hypercalcemia in leprosy. (1985) (26)
- Case report: dextran-induced acute anuric renal failure. (1991) (26)
- Lymphocyte cell lines from vitamin D-dependent rickets type II show functional defects in the 1α,25-dihydroxyvitamin D3 receptor (1990) (25)
- Clinical effects of 1,25-dihydroxyvitamin D3 in uremic patients with overt osteodystrophy. (1980) (25)
- The Normal Menstrual Cycle and the Control of Ovulation -- Endotext (2000) (25)
- 5 – Paget's Disease of Bone (1978) (25)
- Current Concepts of Bone Metabolism (1974) (24)
- Abnormal bone and parathyroid histology in carcinoma patients with pseudohyperparathyroidism (1982) (24)
- Giant cell tumor arising in Paget's disease of bone. Recurrences after 36 years. (1993) (24)
- Clinical efficacy of salmon calcitonin in Paget's disease of bone (2007) (23)
- Relationship between the kidney and parathyroid hormone. (1975) (23)
- Impaired Sensitivity to Thyroid Hormone: Defects of Transport, Metabolism and Action -- Endotext (2000) (22)
- Genetics of endocrine disease: The genetics of paget's disease of the bone (2001) (21)
- Dextran-charcoal and dioxane phase separation methods in the radioimmunoassays for parathyroid hormone and calcitonin. (1973) (21)
- Effect of salmon calcitonin and etidronate on hypercalcemia of malignancy (1992) (20)
- Gallium-67 citrate localization in osteoclast nuclei of Paget's disease of bone. (1988) (20)
- Gallium scanning in Paget's disease of bone: effect of calcitonin. (1980) (20)
- Bone Quality in Paget’s Disease of Bone (2016) (20)
- Hypercalcemia in association with a Leydig cell tumor in the rat: a model for tumor-induced hypercalcemia in man. (1982) (19)
- Use of 1,25(OH)2-vitamin D3 to separate 'types' on renal osteodystrophy. (1977) (19)
- The high incidence of persistent secondary hyperparathyroidism after renal homotransplantation. (1976) (19)
- Thyroid Hormones in Brain Development and Function -- Endotext (2000) (19)
- Specific internalization and action of 1,25-dihydroxyvitamin D3 in cultured dermal fibroblasts from patients with X-linked hypophosphatemia. (1984) (18)
- Paget's Disease: Reversal of Severe Paraparesis Using Calcitonin (1979) (18)
- Long-term culture of cells from bone affected by Paget’s disease (1979) (17)
- Therapy of hypercalcemia of malignancy. (1987) (17)
- Molecular links between Obesity and Diabetes: “Diabesity” -- Endotext (2000) (16)
- Elevated levels of angiotensin-converting enzyme in Pneumocystis carinii pneumonia. (1989) (16)
- Inactivation of calcitonin by specific organs. (1972) (16)
- Risedronate in Paget's disease: preliminary results of a multicenter study. (1994) (16)
- Purification and N-terminal amino acid sequence of the tartrate-resistant acid phosphatase from human osteoclastoma: evidence for a single structure. (1990) (15)
- Persistent insulin resistance after normalization of androgen levels in a woman with congenital adrenal hyperplasia. A case report. (1989) (15)
- Pathogenesis of hypercalcemia of malignancy. (1991) (14)
- The etiology of Paget's disease of bone: viral and genetic interactions. (2011) (13)
- Humoral hypercalcemia of malignancy: a syndrome in search of a hormone. (1982) (13)
- Diseases of Bone and Mineral Metabolism (2000) (13)
- Long-term management and outcome of parathyroidectomy for sporadic primary multiple-gland disease. (2001) (13)
- A viral antigen-bearing cell line derived from culture of Paget's bone cells. (1985) (13)
- Role of the bisphosphonate etidronate in the therapy of cancer-related hypercalcemia. (1990) (13)
- Vitamin D: Production, Metabolism, and Mechanisms of Action -- Endotext (2000) (12)
- End-organ response to adrenocorticotropin, thyrotropin, gonadotropin-releasing hormone, and glucagon in hypocalcemic magnesium deficient patients. (1982) (12)
- A multicenter trial of low dose gallium nitrate in patients with advanced Paget's disease of bone (1995) (12)
- Glucocorticoid Therapy and Adrenal Suppression -- Endotext (2000) (12)
- Paget's disease of bone possible viral basis (1996) (12)
- Sites of clearance of endogenous parathyroid hormone in the vitamin D-deficient dog. (1976) (12)
- In Vitro Synthesis of Normal Bone (Type I) Collagen by Bones of Paget's Disease Patients 1 (1980) (11)
- Diffuse Hormonal Systems and Endocrine Tumor Syndromes (2000) (11)
- Paget's Disease of Bone: Clinical Assessment, Present and Future Therapy (1991) (10)
- Clinical Endocrinology 6 Metabolism Editor-in-chief: Delbert A. Fisher (10)
- Paget's disease: Complications and controversies (1994) (9)
- Generation of a carboxyl-terminal fragment of bovine parathyroid hormone by canine renal plasma membranes. (1974) (9)
- The etiology of Paget's disease of bone. (1977) (9)
- Faculty Opinions recommendation of Parathyroid surgery: an evidence-based volume-outcomes analysis : European Society of Endocrine Surgeons (ESES) positional statement. (2020) (9)
- The use of thermography in the evaluation of the anti-inflammatory activity of feprazone on rheumatoid arthritis. (1982) (8)
- Calcium metabolism in acromegaly. (1969) (8)
- The Genetics of Obesity in Humans -- Endotext (2000) (8)
- Recurrent primary hyperparathyroidism due to Type 1 parathyromatosis (2017) (8)
- Metabolic bone disease: atypical femoral fractures. (2011) (8)
- Metabolism of human thyrotropin in the dog. (1974) (7)
- Functional Anatomy of the Hypothalamus and Pituitary -- Endotext (2000) (7)
- Relationship between urinary calcium and calcium intake during calcitriol administration. (1986) (7)
- The genetics of Paget's disease of the bone. (2001) (7)
- Nutritional Recommendations for Individuals with Diabetes -- Endotext (2000) (7)
- Disorders of the Thyroid Gland in Infancy, Childhood and Adolescence -- Endotext (2000) (7)
- Paget's disease of bone: A slow virus infection? (2006) (6)
- Paget's disease of bone: pathophysiology and diagnosis. (1993) (6)
- Recent advances in the understanding and management of primary hyperparathyroidism (2020) (6)
- Chemistry and Physiology of the Calcitonins: Some Recent Advances (1972) (6)
- Acute effects of administered calcitonin in man (2005) (6)
- Serum thyroid hormone indexes in patients with primary hyperparathyroidism. (1984) (6)
- Pathogenesis of Type 2 Diabetes Mellitus -- Endotext (2000) (6)
- Male Androgenetic Alopecia -- Endotext (2000) (6)
- Adrenal carcinoma presenting with postmenopausal vaginal bleeding. (1991) (5)
- Recovery of beta-cell function postpartum in a patient with insulin-dependent diabetes mellitus. (1988) (5)
- Pathophysiology and Treatment of Pancreatic Neuroendocrine Tumors (PNETs): New Developments -- Endotext (2000) (5)
- Endocrinology of Male Reproduction (2000) (5)
- Action of 1,25-dihydroxycholecalciferol in normal and uraemic man. (1973) (5)
- Hypermethylation of adenosine triphosphate-binding cassette transporter genes in primary hyperparathyroidism and its effect on sestamibi imaging. (2007) (5)
- Homeostasis and action of parathyroid hormone in normal man and patients with mild renal failure. (1975) (5)
- Risedronate in resistant Paget's disease of bone (1992) (5)
- Effect of Pregnancy on Lipid Metabolism and Lipoprotein Levels -- Endotext (2000) (5)
- Malignant bone disease (2003) (4)
- Bone: Do all Paget disease risk genes incriminate the osteoclast? (2010) (4)
- Release of calcitonin by cultures of medullary carcinoma of the thyroid. (1975) (4)
- Development And Microscopic Anatomy Of The Pituitary Gland -- Endotext (2000) (4)
- Multiple Endocrine Neoplasia Type 2A (including Familial Medullary Carcinoma) and Type 2B -- Endotext (2000) (4)
- Paget's disease of bone: classical pathology and electron microscopy. (1994) (4)
- Sexual Dysfunction in Diabetes -- Endotext (2000) (4)
- Hormonal Modifiers of Mineral Metabolism Other Than Parathyroid Hormone, Vitamin D, and Calcitonin (1982) (4)
- Acute and Subacute, and Riedel’s Thyroiditis -- Endotext (2000) (4)
- Treatment of Paget's disease of bone. (1975) (4)
- Risk factors for coronary artery disease: taking the family history. (1991) (4)
- Resistance to Calcitonin (1991) (4)
- Diabetes and Dyslipidemia -- Endotext (2000) (3)
- The evaluation and treatment of Paget's disease of bone. (2020) (3)
- Effectiveness of a 24-hour infusion of etidronate disodium in the treatment of hypercalcemia of malignant disease. A dose-ranging pilot study. (1991) (3)
- Medical management of nonparathyroid hypercalcemia and hypocalcemia. (1996) (3)
- In vivo Morphologic Changes in the Rat Osteoclast Induced by Gallium Nitrate: The Result of Toxicity or Other Effects? (1999) (3)
- UCLA conference: Current concepts of bone metabolism. (1974) (3)
- Adrenal Androgens -- Endotext (2000) (3)
- Evolution of the clinical presentation of Paget's disease of bone (2002) (2)
- The Efficacy of Bisphosphonates for the Treatment of Hypercalcemia (1991) (2)
- In Memoriam Tribute to Jack W Coburn, MD: 1932–2004 (2004) (2)
- Metabolic Syndrome -- Endotext (2000) (2)
- Oral and Injectable (Non-insulin) Pharmacological Agents for Type 2 Diabetes -- Endotext (2000) (2)
- Evaluation of Thyroid Function in Health and Disease -- Endotext (2000) (2)
- Normal Physiology of Growth Hormone in Adults -- Endotext (2000) (2)
- Diagnosis and Treatment of Diseases of Lipid and Lipoprotein Metabolism (2000) (2)
- Radioimmunoassays for Calcitonins: Clinical and Experimental Studies (1972) (2)
- Pagetic osteoclasts formed in vitro: absence of paracrystalline inclusions. (1998) (2)
- A Multimarker Circulating DNA Assay for Assessing Prostate Cancer Patients’ Blood (2009) (2)
- Carcinoid Tumors -- Endotext (2000) (2)
- NON-PHARMACEUTICAL INTERVENTION OPTIONS FOR TYPE 2 DIABETES: Diets and Dietary Supplements (Botanicals, Antioxidants, and Minerals) -- Endotext (2000) (2)
- Heterogeneity of immunoreactive calcitonin in extracts of medullary thyroid carcinoma. (1982) (2)
- Pheochromocytoma and Paraganglioma -- Endotext (2000) (2)
- Overview of Endocrine Hypertension -- Endotext (2000) (2)
- Normal Physiology of Growth Hormone and Insulin-Like Growth Factors in Childhood -- Endotext (2000) (2)
- Ovarian Reserve Testing -- Endotext (2000) (2)
- First 24 hours of acute pancreatitis. A biochemical and endocrine evaluation of initial versus repeated attacks. (1978) (1)
- GALLIUM LOCALIZATION IN THE NUCLEUS OF OSTEOCLASTS IN PATIENTS WITH PAGET'S DISEASE OF BONE.: P21 (1987) (1)
- Faculty Opinions recommendation of 11C-Choline PET/CT for Detection and Localization of Parathyroid Adenomas. (2020) (1)
- The spectrum of pathology in osteomalacia. (1987) (1)
- TBG deficiency in male euthyroid patient with hypothyroxinemia. (1976) (1)
- ACTH Action on the Adrenals -- Endotext (2000) (1)
- Endocrine Testing Protocols (2000) (1)
- Faculty Opinions recommendation of Single gland excision for MEN1-associated primary hyperparathyroidism. (2020) (1)
- The Diabetic Foot -- Endotext (2000) (1)
- A High Prevalence of Hypomagnesemia and Hypermagnesemia in Hospitalized Patients (1983) (1)
- The Measurement of Lipids, Lipoproteins, Apolipoproteins, Fatty Acids, and Sterols, and Next Generation Sequencing for the Diagnosis and Treatment of Lipid Disorders -- Endotext (2000) (1)
- Hypoglycemia During Therapy of Diabetes -- Endotext (2000) (1)
- A Potential Autocrine/Paracnne Factor in Paget's Disease of Bone (1992) (1)
- Response to letter by Ralston et al. (2015) (1)
- The Osteoporosis Primer: Bisphosphonate therapy of osteoporosis (2000) (1)
- High monounsaturated fat diet for non-insulin-dependent diabetes mellitus. (1989) (1)
- Detection of CirculatingTumor Cells in Early-Stage Breast Cancer Metastasis toAxillary Lymph Nodes (2007) (1)
- Faculty Opinions recommendation of Multimodal Preoperative Localization Improves Outcomes in Reoperative Parathyroidectomy: A 25-Year Surgical Experience. (2020) (1)
- Paget's disease of bone: Pathogenesis and treatment (2012) (1)
- Endocrinology of Female Reproduction (2000) (1)
- Table 1. [Bisphosphonates]. (2016) (0)
- Faculty Opinions recommendation of Effect of parathyroidectomy on cardiovascular risk factors in primary hyperparathyroidism: A randomized clinical trial. (2020) (0)
- Figure 1, [The bust of Sir James Paget in the Museum of St. Bartholomew's Hospital.]. (2016) (0)
- Figure 9, A technetium 99m-bisphosphonate bone scan of a patient with polyostotic Paget's disease. (2016) (0)
- Response to letter. (2015) (0)
- Faculty Opinions recommendation of Persistent/recurrent primary hyperparathyroidism: does the number of abnormal glands play a role? (2020) (0)
- Faculty Opinions recommendation of Effect of parathyroidectomy on epicardial fat thickness as a cardiovascular risk factor in patients with primary hyperparathyroidism (2020) (0)
- Faculty Opinions recommendation of Primary hyperparathyroidism in pregnancy: maternofetal outcomes at a quaternary referral obstetric hospital, 2000 through 2015. (2020) (0)
- Figure 13, [Multiple sites of osteogenic sarcoma...]. (2016) (0)
- Faculty Opinions recommendation of Factors associated with late recurrence after parathyroidectomy for primary hyperparathyroidism. (2020) (0)
- Propranolol for lowering serum calcium. (1980) (0)
- Abstracts from the symposium on recent advances in Paget’s disease of bone and related bone diseases (1996) (0)
- Faculty Opinions recommendation of Effects of surgery on the patient-reported outcomes of primary hyperparathyroidism patients with mild hypercalcemia without classic symptoms: a systematic review of the literature. (2020) (0)
- Faculty Opinions recommendation of Coronary artery disease is more severe in patients with primary hyperparathyroidism. (2020) (0)
- Figure 11, [A bone biopsy demonstrating the...]. (2016) (0)
- Faculty Opinions recommendation of Prospective, randomized, controlled trial of parathyroidectomy versus observation in patients with "asymptomatic" primary hyperparathyroidism. (2009) (0)
- Faculty Opinions recommendation of Diagnostic performance of 4D CT and sestamibi SPECT/CT in localizing parathyroid adenomas in primary hyperparathyroidism. (2020) (0)
- [Course of enzymopenic hemolytic anemia (glutathione reductase deficiency) simulating chronic polyarthritis]. (1981) (0)
- Figure 6, Large osteolytic lesion in the skull of a woman with Paget's disease. (2016) (0)
- Faculty Opinions recommendation of Human osteoclast-poor osteopetrosis with hypogammaglobulinemia due to TNFRSF11A (RANK) mutations. (2008) (0)
- Rationale for the Use of A | endronate in Osteoporosis (0)
- Session 11: Metabolic Disorders of Mineralized Tissues (1992) (0)
- Selective hypoaldosteronism and impairment of angiotensin II production. (1987) (0)
- Figure 10, [A bone biopsy of the...]. (2016) (0)
- Treatment options for postmenopausal osteoporosis. (1994) (0)
- Faculty Opinions recommendation of Heterogeneous and low-intensity parathyroid autofluorescence: Patterns suggesting hyperfunction at parathyroid exploration. (2020) (0)
- Figure 8, [Far advanced Paget's disease of...]. (2016) (0)
- Reviews, Notes, and Listings: Metabolic Disease and Nutrition: Disorders of Bone and Mineral Metabolism (1993) (0)
- The treatment of amebic liver abscess with metronidazole (Flagyl): case report of a Vietnam returnee. (1968) (0)
- Editorial comment. (2009) (0)
- 756 CALCIUM, PHOSPHORUS AND PAT BALANCES IN PRETERM INFANTS FED FORMULAS CONTAINING VEGETABLE AND ANIMAL FAT BLENDS (1985) (0)
- Response to the letter by Asik M., et al. (2015) (0)
- Faculty Opinions recommendation of The devil is in the details: Assessing treatment and outcomes of 6,795 patients undergoing remedial parathyroidectomy in the Collaborative Endocrine Surgery Quality Improvement Program. (2020) (0)
- Faculty Opinions recommendation of Intraoperative Parathyroid Hormone Assay Remains Predictive of Cure in Renal Impairment in Patients with Single Parathyroid Adenomas. (2020) (0)
- Chapter 71 – Paget's Disease of Bone (2002) (0)
- Serum ferritin and iron uptake by peripheral blood leucocytes in patients with active rheumatoid arthritis (1982) (0)
- Faculty Opinions recommendation of Impact of intraoperative parathyroid hormone monitoring on the management of patients with primary hyperparathyroidism. (2020) (0)
- Chapter 74 – Paget's Disease of Bone (2008) (0)
- Table 2. [Indications for Treatment]. (2016) (0)
- Pagetic osteoclasts formed in vitro (1998) (0)
- Figure 5, Patient with back pain who has multiple vertebrae affected by Paget's disease, large osteophytes, and narrowed disc spaces. (2016) (0)
- Characteristics of a Two-SiteImmunoradiometric Assayfor HumanSkeletalAlkaline Phosphatasein Serum (1994) (0)
- Faculty Opinions recommendation of Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density. (2009) (0)
- Proceedings: Prostaglandins: effect on plasma calcium concentration. (1974) (0)
- Faculty Opinions recommendation of Seventeen cases of primary hyperparathyroidism in pregnancy: A call for management guidelines. (2020) (0)
- Primary hypo magnesemia of renal origin abnormal renal magnesium threshold and normal magnesium transport maximum (1981) (0)
- Chapter 72 – Paget’s Disease of Bone (2016) (0)
- Advances in Paget's disease treatment (1990) (0)
- [Early identification of inflammatory rheumatic bone diseases via mammography technique (author's transl)]. (1981) (0)
- Faculty Opinions recommendation of Stricter ioPTH criterion for successful parathyroidectomy in stage III CKD patients with primary hyperparathyroidism. (2020) (0)
- Faculty Opinions recommendation of Health-related quality of life improves 1 year after parathyroidectomy in primary hyperparathyroidism: A prospective cohort study. (2020) (0)
- Faculty Opinions recommendation of Autofluorescence imaging of parathyroid glands: An assessment of potential indications. (2020) (0)
- Risedronate : dose response in Paget's disease (1992) (0)
- Faculty Opinions recommendation of Characterization of Calcium Homeostasis in Lithium-Treated Patients Reveals Both Hypercalcaemia and Hypocalcaemia. (2020) (0)
- The diagnosis of Paget’s disease of bone (2004) (0)
- Chapter 26. Recent Developments in the Therapeutics of Disorders of Bone Metabolism (1982) (0)
- Faculty Opinions recommendation of Could the Less-Than Subtotal Parathyroidectomy Be an Option for Treating Young Patients With Multiple Endocrine Neoplasia Type 1-Related Hyperparathyroidism? (2020) (0)
- Faculty Opinions recommendation of Derivation of a cost-saving screening strategy for asymptomatic primary hyperparathyroidism. (2020) (0)
- Faculty Opinions recommendation of Normocalcemic hyperparathyroidism: A Collaborative Endocrine Surgery Quality Improvement Program analysis. (2020) (0)
- Faculty Opinions recommendation of Why is hyperparathyroidism underdiagnosed and undertreated in older adults? (2020) (0)
- Figure 4, [Paget's disease involving the left...]. (2016) (0)
- Figure 7, Osteolytic lesion of the distal left femur which is progressing proximally. (2016) (0)
- Figure 12, [Electron microscopic examination of an...]. (2016) (0)
- Faculty Opinions recommendation of Preoperative risk index among patients undergoing thyroid or parathyroid surgery. (2020) (0)
- Table 3. [Surgery]. (2016) (0)
- Faculty Opinions recommendation of Intraoperative Parathyroid Autofluorescence Detection in Patients with Primary Hyperparathyroidism. (2020) (0)
- [Differential diagnosis of hand and finger changes from a rheumatologic viewpoint]. (1982) (0)
- [Radiologic demonstration of the cervico-thoracic transition]. (1978) (0)
- In memoriam Robert K. Rude(1942-2010) (2011) (0)
- Faculty Opinions recommendation of Intraoperative parathyroid hormone levels ≤40 pg/mL are associated with the lowest persistence rates after parathyroidectomy for primary hyperparathyroidism. (2020) (0)
- Faculty Opinions recommendation of 18F-Fluorocholine PET/CT in the assessment of primary hyperparathyroidism compared with 99mTc-MIBI or 99mTc-tetrofosmin SPECT/CT: a prospective dual-centre study in 100 patients. (2020) (0)
- Faculty Opinions recommendation of High rate of occult urolithiasis in normocalcemic primary hyperparathyroidism. (2020) (0)
- Figure 2, Typical bowing of the leg due to Paget's disease involving the right tibia. (2016) (0)
- Magnesium deficiency: an unrecognized cause of convulsions, arrhythmias, and neuromuscular impairment. (1980) (0)
- Figure 3, Transverse fracture of the left femur. (2016) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Frederick R. Singer?
Frederick R. Singer is affiliated with the following schools:
